| JXSS2500037 | 度伐利尤单抗注射液 | durvalumab | Injection | Biological Products(3.1) | Import Drug Application | 2025-03-28 | | AstraZeneca AB;Catalent Indiana LLC;Astrazeneca Investment (China) Co Ltd;Astrazeneca Uk Ltd | | | view |
| JYSB2300138 | 度伐利尤单抗注射液 | durvalumab | Injection | Biological Products | Supplementary Application | 2023-08-17 | | Catalent Indiana LLC;Astrazeneca Uk Ltd | | | view |
| JXSL2200085 | 度伐利尤单抗注射液 | durvalumab | Injection | Biological Products(2.2) | Import Drug Application | 2022-06-14 | | Medimmune LLC;Astrazeneca Investment (China) Co Ltd | | | view |
| JYSB2000113 | 度伐利尤单抗注射液 | durvalumab | Injection | Biological Products | Supplementary Application | 2020-04-09 | | Medimmune LLC;Cook Pharmica LLC | In Review | 2020-04-08 | view |
| JXSS2400096 | 度伐利尤单抗注射液 | durvalumab | Injection | Biological Products(3.1) | Import Drug Application | 2024-10-18 | | Catalent Indiana LLC;Astrazeneca Investment (China) Co Ltd;Astrazeneca Uk Ltd | | | view |
| JXSL2101125 | 度伐利尤单抗注射液 | durvalumab | Injection | Biological Products(2.2) | Import Drug Application | 2021-11-05 | | Medimmune LLC;Astrazeneca Investment (China) Co Ltd | | | view |
| JXSB2000012 | 度伐利尤单抗注射液 | durvalumab | Injection | Biological Products(2.2) | Supplementary Application | 2020-09-10 | | Medimmune LLC;Catalent Indiana LLC | In Review | 2020-09-09 | view |
| JXSS2500018 | 度伐利尤单抗注射液 | durvalumab | Injection | Biological Products(2.2) | Import Drug Application | 2025-02-25 | | Astrazeneca Investment (China) Co Ltd;Astrazeneca Uk Ltd | | | view |
| JYSB2300055 | 度伐利尤单抗注射液 | durvalumab | Injection | Biological Products | Supplementary Application | 2023-03-22 | | Catalent Indiana LLC;Astrazeneca Uk Ltd | | | view |
| JXSB2100011 | 度伐利尤单抗注射液 | durvalumab | Injection | Biological Products | Supplementary Application | 2021-02-06 | | Medimmune LLC;Catalent Indiana LLC | In Review | 2021-02-05 | view |
| JYSZ2400002 | 度伐利尤单抗注射液 | durvalumab | Injection | Biological Products | License Renew | 2024-01-03 | | Catalent Indiana LLC;Astrazeneca Investment (China) Co Ltd;Astrazeneca Uk Ltd | | | view |
| JYSB2200077 | 度伐利尤单抗注射液 | durvalumab | Injection | Biological Products | Supplementary Application | 2022-04-24 | | Catalent Indiana LLC;Astrazeneca Uk Ltd | | | view |
| JXSS2000030 | 度伐利尤单抗注射液 | durvalumab | Injection | Biological Products(3.1) | Import Drug Application | 2020-07-24 | 阿斯利康投资(中国)有限公司 | Astrazeneca Investment (China) Co Ltd;Catalent Indiana LLC;Astrazeneca Uk Ltd | Certificate Issued | 2021-07-15 | view |
| JYSB2500039 | 度伐利尤单抗注射液 | durvalumab | Injection | Biological Products | Supplementary Application | 2025-02-15 | | Astrazeneca Uk Ltd | | | view |
| JXSL2300031 | 度伐利尤单抗注射液 | durvalumab | Injection | Biological Products(2.2) | Import Drug Application | 2023-02-02 | | Astrazeneca Investment (China) Co Ltd;Astrazeneca Uk Ltd | | | view |
| JXSB2000041 | 度伐利尤单抗注射液 | durvalumab | Injection | Biological Products | Supplementary Application | 2020-12-03 | | Medimmune LLC;Catalent Indiana LLC | In Review | 2020-12-03 | view |
| JXSS2400098 | 度伐利尤单抗注射液 | durvalumab | Injection | Biological Products(3.1) | Import Drug Application | 2024-10-18 | | Catalent Indiana LLC;Astrazeneca Investment (China) Co Ltd;Astrazeneca Uk Ltd | | | view |
| JYSB2200176 | 度伐利尤单抗注射液 | durvalumab | Injection | Biological Products | Supplementary Application | 2022-09-10 | | Catalent Indiana LLC;Astrazeneca Uk Ltd | | | view |
| JXSB2000009 | 度伐利尤单抗注射液 | durvalumab | Injection | Biological Products | Supplementary Application | 2020-08-21 | | Medimmune LLC;Catalent Indiana LLC | In Review | 2020-08-19 | view |
| JXSS2500017 | 度伐利尤单抗注射液 | durvalumab | Injection | Biological Products(2.2) | Import Drug Application | 2025-02-25 | | Astrazeneca Investment (China) Co Ltd;Astrazeneca Uk Ltd | | | view |
